Animal Health Leaders Embrace Biotech R&D

Summary: Animal health companies are increasingly taking biotech advances that have revolutionized human health and adapting them for veterinary use. Of particular interest are human monoclonal antibodies (mAbs), which emerged in the 1990s and are now used to treat a range of human diseases, from cancer to autoimmune disorders such as rheumatoid arthritis.

Click here to download eBook.